Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MaxCyte ( (MXCT) ) just unveiled an update.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. crossing a significant threshold in voting rights. The notification indicates that BlackRock now holds 7.76% of the voting rights in MaxCyte, reflecting a slight decrease from the previous 7.87%. This adjustment in holdings could have implications for MaxCyte’s governance and influence within the company, as BlackRock is a major player in the financial industry.
More about MaxCyte
YTD Price Performance: -41.51%
Average Trading Volume: 36,307
Technical Sentiment Signal: Strong Buy
Current Market Cap: £203.3M
For an in-depth examination of MXCT stock, go to TipRanks’ Stock Analysis page.